Insight Molecular Diagnostics Inc. (IMDX) Gross profit 2020–2025
Insight Molecular Diagnostics Inc. (IMDX) annual gross profit history from SEC filings — each fiscal year as reported.
$2.3MFY2025 · since FY2020: -$639,000 → $2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.3M | +210.5% |
| FY2024 | $740,000 | +79.2% |
| FY2023 | $413,000 | +2394.4% |
| FY2022 | -$18,000 | -101.3% |
| FY2021 | $1.4M | +322.2% |
| FY2020 | -$639,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice